Home » Blog » Seeking Alpha: Oramed oral COVID vaccine shows promise in phase 1 trial

Seeking Alpha: Oramed oral COVID vaccine shows promise in phase 1 trial

  • by

Oct. 07, 2022 9:13 AM ETOramed Pharmaceuticals Inc. (ORMP)By: Ravikash, SA News Editor

Modern Medicine Research Laboratory: Diverse Team of Multi-Ethnic Young Scientists Analysing Test Samples. Advanced Lab with High-Tech Equipment, Microbiology Researchers Design, Develop Drugs
gorodenkoff

Oramed oral COVID vaccine shows promise in phase 1 trial | Seeking Alpha

Leave a Reply

Your email address will not be published.